The presentation will cover the Human Papilloma Virus (HPV), HPV-related diseases, the role of vaccination and how vaccination has affected the disease burden since it has been available. We will cover the National Immunisation Programme (NIP) in 2008 and its extension to a gender-neutral programme from September 2019, discussing eligible groups. Additionally, we will consider the pharmacist’s role in promoting and signposting patients to the NIP and explore which patients may wish to access vaccination through a paid-for private service.